Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen

Abstract

At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age of 93, during a routine examination, the patient was found to have palpable adenopathy and underwent a fine needle aspiration in June 2010. Pathology revealed similar histologic characteristics of her 2001 BCAC diagnosis, and further IHC stains revealed positive estrogen receptor staining.

Keywords

• Basal cell adenocarcinoma
• estrogen receptor
• tamoxifen
• supraglottic larynx